Serum α-synuclein and IL-1β are increased and correlated with measures of disease severity in children with epilepsy: potential prognostic biomarkers?

Isolation and quantitation of exosomes isolated from human plasma via hydrophobic interaction chromatography using a polyester, capillary-channeled polymer fiber phase

(2019) Lei Wang et al.   ANALYTICA CHIMICA ACTA

Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation

(2018) Gaetano Terrone et al.   CURRENT PHARMACEUTICAL DESIGN

Epilepsy biomarkers – Toward etiology and pathology specificity

(2018) Asla Pitkänen et al.   NEUROBIOLOGY OF DISEASE

Significant Changes in Plasma Alpha-Synuclein and Beta-Synuclein Levels in Male Children with Autism Spectrum Disorder

(2018) Wilaiwan Sriwimol et al.   Biomed Research International

Increased serum exosomal miR-134 expression in the acute ischemic stroke patients

(2018) Jingxia Zhou et al.   BMC Neurology

Regression in children with epilepsy

(2018) Peter Camfield et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

(2017) Ingrid E. Scheffer et al.   EPILEPSIA

Advances in the development of biomarkers for epilepsy

(2016) Asla Pitkänen et al.   LANCET NEUROLOGY

Review: The spectrum of clinical features seen with alpha synuclein pathology

(2016) R. A. Barker et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

(2015) Dean M. Wingerchuk et al.   NEUROLOGY

Alpha-synuclein is a potential biomarker in the serum and CSF of patients with intractable epilepsy

(2015) Hu Rong et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

(2014) Min Shi et al.   ACTA NEUROPATHOLOGICA

IL-1β associations with posttraumatic epilepsy development: A genetics and biomarker cohort study

(2014) Matthew L. Diamond et al.   EPILEPSIA

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions

(2013) Lauren B Krupp et al.   Multiple Sclerosis Journal

Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase

(2012) Honghao Wang et al.   JOURNAL OF NEUROCHEMISTRY

Levetiracetam-Induced Reversible Autistic Regression

(2012) Ana Camacho et al.   PEDIATRIC NEUROLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Standards for epidemiologic studies and surveillance of epilepsy

(2011) David J. Thurman et al.   EPILEPSIA

α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases

(2011) Zane S. Martin et al.   JOURNAL OF NEUROCHEMISTRY

Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures

(2011) Jieun Choi et al.   Journal of Neuroinflammation

Proteomic Profiling of the Epileptic Dentate Gyrus

(2010) Aiqing Li et al.   BRAIN PATHOLOGY

The role of inflammation in epilepsy

(2010) Annamaria Vezzani et al.   Nature Reviews Neurology

Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

(2009) Patrick Kwan et al.   EPILEPSIA

Axonal and neuronal pathology in multiple sclerosis: What have we learnt from animal models

(2009) Hans Lassmann   EXPERIMENTAL NEUROLOGY

Cellular injury and neuroinflammation in children with chronic intractable epilepsy

(2009) Jieun Choi et al.   Journal of Neuroinflammation

Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood

(2008) Robin Barbour et al.   Neurodegenerative Diseases

Role of Brain Inflammation in Epileptogenesis

(2008) Jieun Choi et al.   YONSEI MEDICAL JOURNAL